BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30144447)

  • 1. Arrhythmias precede cardiomyopathy and remodeling of Ca
    Montnach J; Chizelle FF; Belbachir N; Castro C; Li L; Loussouarn G; Toumaniantz G; Carcouët A; Meinzinger AJ; Shmerling D; Benitah JP; Gómez AM; Charpentier F; Baró I
    J Mol Cell Cardiol; 2018 Oct; 123():13-25. PubMed ID: 30144447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
    Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA
    Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mutations in the SCN5A gene in cardiomyopathies.
    Zaklyazminskaya E; Dzemeshkevich S
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1799-805. PubMed ID: 26916278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
    Potet F; Beckermann TM; Kunic JD; George AL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
    Nieto-Marín P; Tinaquero D; Utrilla RG; Cebrián J; González-Guerra A; Crespo-García T; Cámara-Checa A; Rubio-Alarcón M; Dago M; Alfayate S; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Tamargo J; Bernal JA; Caballero R; Delpón E;
    Cardiovasc Res; 2022 Mar; 118(4):1046-1060. PubMed ID: 33576403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
    Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
    J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome.
    Qi X; Yeh YH; Chartier D; Xiao L; Tsuji Y; Brundel BJ; Kodama I; Nattel S
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):295-304. PubMed ID: 19808480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.
    Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG
    Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction.
    Guzadhur L; Pearcey SM; Duehmke RM; Jeevaratnam K; Hohmann AF; Zhang Y; Grace AA; Lei M; Huang CL
    Pflugers Arch; 2010 Aug; 460(3):593-601. PubMed ID: 20552221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
    Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q
    Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN5A variant R222Q generated abnormal changes in cardiac sodium current and action potentials in murine myocytes and Purkinje cells.
    Daniel LL; Yang T; Kroncke B; Hall L; Stroud D; Roden DM
    Heart Rhythm; 2019 Nov; 16(11):1676-1685. PubMed ID: 31125670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
    Wilde AAM; Amin AS
    JACC Clin Electrophysiol; 2018 May; 4(5):569-579. PubMed ID: 29798782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Consequences of the
    Casini S; Albesa M; Wang Z; Portero V; Ross-Kaschitza D; Rougier JS; Marchal GA; Chung WK; Bezzina CR; Abriel H; Remme CA
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced late sodium current underlies pro-arrhythmic intracellular sodium and calcium dysregulation in murine sodium channelopathy.
    Rivaud MR; Baartscheer A; Verkerk AO; Beekman L; Rajamani S; Belardinelli L; Bezzina CR; Remme CA
    Int J Cardiol; 2018 Jul; 263():54-62. PubMed ID: 29754923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.
    Wang DW; Crotti L; Shimizu W; Pedrazzini M; Cantu F; De Filippo P; Kishiki K; Miyazaki A; Ikeda T; Schwartz PJ; George AL
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):370-8. PubMed ID: 19808432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.
    Beckermann TM; McLeod K; Murday V; Potet F; George AL
    Heart Rhythm; 2014 Aug; 11(8):1446-53. PubMed ID: 24815523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Base Editing of
    Qi M; Ma S; Liu J; Liu X; Wei J; Lu WJ; Zhang S; Chang Y; Zhang Y; Zhong K; Yan Y; Zhu M; Song Y; Chen Y; Hao G; Wang J; Wang L; Lee AS; Chen X; Wang Y; Lan F
    Circulation; 2024 Jan; 149(4):317-329. PubMed ID: 37965733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
    Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P
    Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice.
    Fabritz L; Kirchhof P; Franz MR; Nuyens D; Rossenbacker T; Ottenhof A; Haverkamp W; Breithardt G; Carmeliet E; Carmeliet P
    Cardiovasc Res; 2003 Mar; 57(4):1085-93. PubMed ID: 12650887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.